Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Xcyte Digital Corp. Releases "Xperience" Subscription Service (click to learn more) Star Diamond: High Modelled Diamond Prices and High Proportions of Type IIa Diamonds (click to learn more) Northstar Discovers Large Near Surface EM Conductor SE of Cam Copper Mine (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Marker Therapeutics Inc MRKR

Healthcare Biotechnology
Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company. The Company specializes in the development and commercialization of novel T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications. It has developed its lead product candidates from its multiTAA-specific T cell technology, which is based on the manufacture of non-engineered... see more

Recent & Breaking News (NDAQ:MRKR)

TapImmune Provides Update on PolyStart(TM) Vaccine Platform Applicable to Cancer and Infectious Disease

Business Wire October 22, 2014

What's Next: Investors Place Ebola Pandemic Stock Bets

Accesswire October 6, 2014

TapImmune CEO Provides Update on Corporate Activity and Progression of Clinical Programs

Business Wire September 23, 2014

SeeThruEquity Issues Company Update on TapImmune Highlighting Positive Clinical Trial Data

Accesswire September 18, 2014

TapImmune Releases Positive Interim Data on Phase I Clinical Trial of Folate Receptor Alpha Antigens in Ovarian and Breast Cancer

Business Wire September 16, 2014

SeeThruEquity Fall Microcap Investor Conference To Be Held September 11, 2014

Accesswire September 8, 2014

TapImmune, Inc. to Present at SeeThruEquity Microcap Conference

Accesswire September 4, 2014

TapImmune Inc to Present at 16th Annual Rodman & Renshaw Healthcare Conference

Accesswire September 3, 2014

SeeThruEquity Issues Update Note on TapImmune Highlighting New Grant Funded Clinical Trial and Recent Capital Raise of $2 Million

Accesswire August 19, 2014

TapImmune, Inc. Announces $2 Million Registered Direct Offering

Business Wire August 11, 2014

TapImmune's New Clinical Trial in Advanced Stage Ovarian Cancer Expands the Use of Folate Receptor Alpha Peptide Antigens

Business Wire August 7, 2014

TapImmune Prevails in Legal Dispute with Michael Gardner

Business Wire July 24, 2014

New Immunotherapy Technologies Provide Hope In Breast and Ovarian Cancer

Accesswire July 23, 2014

SeeThruEquity Issues Company Note on TapImmune Highlighting Valuation as Compared with Peers

Accesswire July 1, 2014

TapImmune Appoints Leading Immunotherapy Researcher to Chair Scientific Advisory Board

Business Wire June 12, 2014

SeeThruEquity Initiates Research Coverage on TapImmune with Target Price of $6.97

Accesswire May 27, 2014

TapImmune Inc. Is Pleased to Provide an Update on Corporate Events and Developments

Accesswire May 23, 2014

TapImmune Inc. to Present at 3rd Annual SeeThroughEquity Microcap Investor Conference in New York on May 28th 2014

Accesswire May 15, 2014

TapImmune Inc. to Present at Invitation Only Corporate Roadshow in Boca Raton Florida

Accesswire April 24, 2014

TapImmune Inc. is Pleased to Provide an Update on Corporate Events and Milestones for 2014

Business Wire April 3, 2014